Par Drugs And Chemicals Limited
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, m… Read more
Par Drugs And Chemicals Limited (PAR) - Total Liabilities
Latest total liabilities as of September 2025: ₹210.91 Million INR
Based on the latest financial reports, Par Drugs And Chemicals Limited (PAR) has total liabilities worth ₹210.91 Million INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Par Drugs And Chemicals Limited - Total Liabilities Trend (2016–2025)
This chart illustrates how Par Drugs And Chemicals Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Par Drugs And Chemicals Limited Competitors by Total Liabilities
The table below lists competitors of Par Drugs And Chemicals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
UCB - Dusseldorf Stock Exchang
DU:UNC
|
Germany | €6.56 Billion |
|
RENAISSANCERE HLDG
BE:RRJ
|
Germany | €34.65 Billion |
|
Palatin Technologies Inc
NYSE MKT:PTN
|
USA | $10.12 Million |
|
CREDICORP
BE:D8V
|
Germany | €215.04 Billion |
|
CARLO GAVAZZI
BE:D9N
|
Germany | €42.84 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Par Drugs And Chemicals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.57 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Par Drugs And Chemicals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Par Drugs And Chemicals Limited (2016–2025)
The table below shows the annual total liabilities of Par Drugs And Chemicals Limited from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹204.15 Million | +27.76% |
| 2024-03-31 | ₹159.79 Million | -9.36% |
| 2023-03-31 | ₹176.30 Million | -6.29% |
| 2022-03-31 | ₹188.13 Million | -22.16% |
| 2021-03-31 | ₹241.70 Million | +23.94% |
| 2020-03-31 | ₹195.01 Million | -12.31% |
| 2019-03-31 | ₹222.38 Million | -33.10% |
| 2018-03-31 | ₹332.40 Million | -9.77% |
| 2017-03-31 | ₹368.38 Million | -9.43% |
| 2016-03-31 | ₹406.75 Million | -- |